Buy or sell Schrodinger stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Schrodinger Stock

Computational drug design

Founded

1990

Notable Investors

Bill & Melinda Gates Foundation

Headquarters

New York NY, US

Total Funding

$137M

About Schrodinger Stock

Schrödinger is a scientific developer of computational drug design for pharmaceutical and biotechnology research.

Investors

Funding History

April 2010$10.0M
December 2012$20.0M
June 2015$22.0M
January 2019$85.0M

Management

Chief Biomedical Scientist

Karen Akinsanya

Chief Financial Officer

Joel Lebowitz

Chief Business Officer

Cony D'Cruz

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Schrodinger or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 140K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo